Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction

Affiliations

• ¹ Novartis Institutes for Biomedical Research, Cambridge, MA (L.Z., J.J., M.M.M., D.P.Y., M.H., C.-W.C., G.M.T., N.L.P.-M., F.Z., M.T.B., J.M.L., W.C.).
• ² Brigham and Women's Hospital, Boston, MA (J.W.C., B.L.C., S.D.S.).
• ³ Novartis Institutes for Biomedical Research, Basel, Switzerland (P.S.-F., S.K.).
• ⁴ Ohio State University Wexner Medical Center, Columbus (W.T.A.).
• ⁵ British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., J.J.V.M.).
• ⁶ Rigshospitalet Copenhagen University Hospital, Denmark (L.K.).
• ⁷ Baylor University Medical Center, Dallas, TX (M.P.).
• ⁸ Montreal Heart Institute and Université de Montréal, Canada (J.R.).
• ⁹ Ralph H. Johnson Department of Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.).
• ¹⁰ Novartis, East Hanover, NJ (M.F.P., M.L.).